Free Trial

Zenas Biopharma (ZBIO) News Today

Zenas Biopharma logo
$10.56 -0.87 (-7.61%)
As of 05/27/2025 04:00 PM Eastern

Why is Zenas Biopharma Dropping Today?

Zenas Biopharma, Inc. (ZBIO) shares have come under pressure amid a surge of investor litigation activity and little offsetting news.

  • May short interest remained at zero shares, yielding a 0.0-day short-interest ratio based on average daily volume.
  • At least six shareholder-rights firms—including Levi & Korsinsky, Rosen Law Firm, Pomerantz LLP, Schall Law Firm, Bronstein, Gewirtz & Grossman, and Robbins Geller Rudman & Dowd—have filed or announced securities class action suits alleging misrepresentations in ZBIO’s September 2024 IPO, with a June 16, 2025 deadline to seek lead-plaintiff status.
Posted 7h agoAI Generated. May Contain Errors.

ZBIO Latest News

What is Wedbush's Forecast for Zenas Biopharma Q2 Earnings?
Zenas Biopharma Inc stock logo
What is Wedbush's Estimate for Zenas Biopharma Q2 Earnings?
Zenas Biopharma Inc (NASDAQ:ZBIO - Free Report) - Research analysts at Wedbush lifted their Q2 2025 earnings per share estimates for shares of Zenas Biopharma in a report issued on Thursday, May 15th. Wedbush analyst M. Fan now forecasts that the company will earn ($1.03) per share for the quarte
Wedbush Forecasts Zenas Biopharma FY2027 Earnings
Get Zenas Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter.

ZBIO Media Mentions By Week

ZBIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZBIO
News Sentiment

0.08

1.03

Average
Medical
News Sentiment

ZBIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZBIO Articles
This Week

18

14

ZBIO Articles
Average Week

Get Zenas Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZBIO) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners